Danske Bank A S Invests $61.97 Million in Danaher Corporation $DHR

Danske Bank A S bought a new position in shares of Danaher Corporation (NYSE:DHR) in the second quarter, according to the company in its most recent filing with the SEC. The firm bought 325,355 shares of the conglomerate’s stock, valued at approximately $61,974,000.

Several other institutional investors have also recently added to or reduced their stakes in DHR. Sivia Capital Partners LLC increased its holdings in shares of Danaher by 6.3% during the second quarter. Sivia Capital Partners LLC now owns 2,009 shares of the conglomerate’s stock worth $397,000 after buying an additional 119 shares in the last quarter. First Trust Advisors LP boosted its holdings in shares of Danaher by 34.5% in the 2nd quarter. First Trust Advisors LP now owns 55,418 shares of the conglomerate’s stock worth $10,947,000 after acquiring an additional 14,217 shares in the last quarter. Main Street Financial Solutions LLC boosted its holdings in shares of Danaher by 40.2% in the 2nd quarter. Main Street Financial Solutions LLC now owns 3,088 shares of the conglomerate’s stock worth $610,000 after acquiring an additional 886 shares in the last quarter. Ieq Capital LLC grew its position in Danaher by 64.2% during the 2nd quarter. Ieq Capital LLC now owns 75,714 shares of the conglomerate’s stock worth $14,957,000 after acquiring an additional 29,592 shares during the last quarter. Finally, HUB Investment Partners LLC grew its position in Danaher by 30.7% during the 2nd quarter. HUB Investment Partners LLC now owns 1,383 shares of the conglomerate’s stock worth $273,000 after acquiring an additional 325 shares during the last quarter. 79.05% of the stock is owned by institutional investors.

Danaher Stock Performance

Shares of DHR stock opened at $199.62 on Wednesday. The stock has a market cap of $140.33 billion, a PE ratio of 35.46, a price-to-earnings-growth ratio of 2.52 and a beta of 0.78. The stock has a 50-day moving average of $193.74 and a 200-day moving average of $192.50. The company has a debt-to-equity ratio of 0.48, a current ratio of 1.65 and a quick ratio of 1.25. Danaher Corporation has a one year low of $160.93 and a one year high of $242.80.

Danaher (NYSE:DHR) last posted its earnings results on Monday, July 20th. The conglomerate reported $1.94 earnings per share for the quarter, topping the consensus estimate of $1.85 by $0.09. Danaher had a return on equity of 11.04% and a net margin of 15.95%.The firm had revenue of $6.26 billion for the quarter, compared to analyst estimates of $6.12 billion. During the same period in the previous year, the company posted $0.77 earnings per share. The company’s revenue for the quarter was up 5.5% on a year-over-year basis. As a group, sell-side analysts expect that Danaher Corporation will post 8.53 earnings per share for the current year.

Wall Street Analyst Weigh In

A number of analysts have recently weighed in on DHR shares. Stifel Nicolaus lowered their target price on Danaher from $260.00 to $220.00 and set a “buy” rating for the company in a research note on Wednesday, July 22nd. Wall Street Zen lowered shares of Danaher from a “buy” rating to a “hold” rating in a report on Saturday, April 25th. Royal Bank Of Canada raised their price objective on shares of Danaher from $200.00 to $215.00 and gave the company an “outperform” rating in a research report on Wednesday, July 22nd. Argus dropped their target price on shares of Danaher from $265.00 to $230.00 and set a “buy” rating for the company in a research note on Friday, April 24th. Finally, UBS Group reduced their target price on shares of Danaher from $270.00 to $250.00 and set a “buy” rating on the stock in a research report on Wednesday, April 22nd. One equities research analyst has rated the stock with a Strong Buy rating, nineteen have issued a Buy rating and five have given a Hold rating to the stock. Based on data from MarketBeat.com, the company presently has an average rating of “Moderate Buy” and a consensus target price of $228.91.

About Danaher

Danaher Corporation (NYSE: DHR) is a global science and technology company that designs, manufactures and markets products and services for the life sciences, diagnostics, and environmental and applied markets. The company organizes its operations into business segments focused on Life Sciences, Diagnostics, and Environmental & Applied Solutions, supplying instruments, reagents, software and related services that support research, clinical testing, biopharmaceutical development, and industrial and environmental monitoring.

Products and services in Danaher’s portfolio include analytical and diagnostic instruments, laboratory consumables and reagents, digital and software solutions for workflow and data management, field and industrial monitoring equipment, and service and maintenance programs.